Growth and quantification of MERS-CoV infection

Current Protocols in Microbiology

Volumn 2015, Issue , 2015, Pages 15E.2.1-15E.2.9

  Coleman, Christopher M ^a   Frieman, Matthew B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Coronavirus; Infection; MERS; Plaque assay; Quantification; Virology

Indexed keywords

MESSENGER RNA; VIRUS RNA;

ARTICLE; CORONAVIRUS INFECTION; IN VITRO STUDY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE; VERO CELL LINE; VIRAL PLAQUE ASSAY; VIROGENESIS; VIRUS REPLICATION; ANIMAL; CHLOROCEBUS AETHIOPS; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; PROCEDURES; VIRUS CULTURE; VIRUS LOAD;

ANIMALS; CERCOPITHECUS AETHIOPS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RNA, VIRAL; VERO CELLS; VIRAL LOAD; VIRUS CULTIVATION;

EID: 84949220116     PISSN: 19348525     EISSN: 19348533     Source Type: Journal    
DOI: 10.1002/9780471729259.mc15e02s37     Document Type: Article

References (15)

1. Chan, J.F., Chan, K.H., Choi, G.K., To, K.K., Tse, H., Cai, J.P., Yeung, M.L., Cheng, V.C., Chen, H., Che, X.Y., Lau, S.K., Woo, P.C., and Yuen, K.Y., 2013. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: Implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 207:1743-1752.
2. Coleman, C.M., Matthews, K.L., Goicochea, L., and Frieman, M.B., 2013. Wild type and innate immune deficient mice are not susceptible to the Middle East Respiratory Syndrome Coronavirus. J. Gen. Virol. 95(Pt 2):408-412.
3. de Wit, E., Prescott, J., Baseler, L., Bushmaker, T., Thomas, T., Lackemeyer, M.G., Martellaro, C., Milne-Price, S., Haddock, E., Haagmans, B.L., Feldmann, H., and Munster, V.J., 2013a. The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PloS One 8:e69127.
4. de Wit, E., Rasmussen, A.L., Falzarano, D., Bushmaker, T., Feldmann, F., Brining, D.L., Fischer, E.R., Martellaro, C., Okumura, A., Chang, J., Scott, D., Benecke, A.G., Katze, M.G., Feldmann, H., and Munster, V.J., 2013b. Middle East respiratory syndrome coronavirus (MERSCoV) causes transient lower respiratory tract infection in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 110:16598-16603.
5. Falzarano, D., deWit, E., Feldmann, F., Rasmussen, A.L., Okumura, A., Peng, X., Thomas, M.J., van Doremalen, N., Haddock, E., Nagy, L., La- Casse, R., Liu, T., Zhu, J., McLellan, J.S., Scott, D.P., Katze, M.G., Feldmann, H., and Munster, V.J., 2014. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 10:e1004250.
6. Frieman, M. and Baric, R., 2008. Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation. Microbiol. Mol. Biol. Rev. 72:672-685.
7. Matthews, K.L., Coleman, C.M., van der Meer, Y., Snijder, E.J., and Frieman, M.B., 2014. The ORF4b-encoded accessory proteins of MERS-Coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signaling. J. Gen. Virol. 95(Pt 4): 874-882.
8. Niemeyer, D., Zillinger, T., Muth, D., Zielecki, F., Horvath, G., Suliman, T., Barchet, W., Weber, F., Drosten, C., and Muller, M.A., 2013. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J. Virol. 87:12489-12495.
9. Pasternak, A.O., Spaan, W.J., and Snijder, E.J., 2006. Nidovirus transcription: How to make sense ? J. Gen. Virol. 87:1403-1421.
10. Phelan, M.C. 2006. Techniques for mammalian cell tissue culture. Curr. Protoc. Mol. Biol. 74:A.3F.1-A.3F.18.
11. Reed, L.J. and Muench, H, 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27:493-497.
12. Siu, K.L., Yeung, M.L., Kok, K.H., Yuen, K.S., Kew, C., Lui, P.Y., Chan, C.P., Tse, H., Woo, P.C., Yuen, K.Y., and Jin, D.Y., 2014. Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J. Virol. 88:4866-4876.
13. van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T.M., Raj, V.S., Zaki, A.M., Osterhaus, A.D., Haagmans, B.L., Gorbalenya, A.E., Snijder, E.J., and Fouchier, R.A., 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3(6). pii: e00473-12.
14. Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., Zhao, Z., and Tan, W., 2013. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 4:951-961.
15. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., and Fouchier, R.A., 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367:1814-1820.